Vendor Intelligence Report: Blessed Peptides

Executive summary

Across 5 Finnrick lab tests, Blessed Peptides shows 4 pass / 1 fail, for an overall pass rate of 80%. That headline is usable, but thin: every sample in the record was vendor-submitted through Finnrick Pulse on the same day rather than built from repeat blind market buys. The product story is uneven. Kisspeptin and KPV sit at the stronger end, Retatrutide passed on a single-sample signal, while SS-31 is the decisive negative; the stricter scoring view keeps the concern focused on fill control rather than identity or purity alone.

The non-lab record reads like a launch in progress rather than a mature storefront. The live homepage remains in a launch-placeholder state, the payment subdomain resolves to GoDaddy Payments but returns an inactive pay-link page, and the reviewed site source does not publish products, COAs, terms, ownership, a legal entity, or official channels. Registry searches in Delaware, Florida, and OpenCorporates produced no Blessed Peptides entity, leaving buyers without a clean public accountability anchor.

The investigation also maps a narrower social-first commercial surface. An Instagram/Linktree promoter path carries a Blessed source route and discount code, while an Ascension Peptides referral route confirms a commercial link whose supplier, affiliate, white-label, or ownership meaning is unresolved. The review surface is largely blank, so the buyer decision leans heavily on the small Pulse lab set and the ordering-channel ambiguity rather than community history.

Inside the full report:

• Complete product-by-methodology breakdown and methodology-divergence charts for all five products, with Pulse context and Appendix A laboratory data
• Dated launch timeline covering domain registration, certificate-transparency payment records, and July storefront captures
• Corporate registry negative-search trail across Delaware, Florida, and OpenCorporates, plus WHOIS and source-code accountability findings
• Website and payment-rails screenshots for the launch-placeholder homepage and GoDaddy Payments inactive link state
• Affiliate and referral analysis of the Instagram/Linktree promoter route and Ascension Peptides commercial link
• Reputation-surface review covering PeptideAtlas, Reddit and coupon-search absences, and monitoring leads

Risk assessment

• SS-31 dosing-accuracy risk — high: Vendor-submitted Pulse lab record shows SS-31 labeled 50 mg but measured at 7.8 mg (84.4% underdose); SS-31 failed Finnrick testing.
• Thin, vendor-submitted testing-base risk — medium: All five Finnrick samples in the record were submitted through Pulse on one date; evidence, but not a blind-purchase track record.
• Corporate and operator-transparency risk — medium: No Blessed Peptides entity found in Delaware, Florida, or OpenCorporates; site/WHOIS do not disclose owner/address/registered agent.
• Affiliate-promotion and ordering-channel ambiguity risk — medium: Sales signals run via Instagram/Linktree discount-code promotion while the official site shows no products, COAs, official channels, or active public checkout.